PreprintAll rights reservedmedRxiv
PATIENT PROFILING AND OUTCOME OF ANTIHYPERTENSIVE TREATMENT. An Exploratory Analysis of the VALUE Trial.
- 1Maastricht University Medical Center
Related
- Tissue-based PEG10 expression as an exploratory biomarker associated with first-line R-CHOP treatment outcome in diffuse large B-cell lymphoma
- Genome Profiling of Actionable Cancer Targets (NYU LG-PACT) for Clinical Patient Molecular Diagnostics and Treatment
- Patient preferences for antihypertensive medication dispensing trade-offs in cardiovascular disease prevention: national survey in Australia
- Development, validation and initial application of a patient-reported outcome measure to assess treatment burden for people living with multimorbidity in low-income settings in South Africa (SIMMBA)
- Exploratory transcriptomic profiling of melittin's efficacy in the treatment of murine cervical cancer cells.
BibTeX
@misc{leeuw2026patient,
title = {{PATIENT PROFILING AND OUTCOME OF ANTIHYPERTENSIVE TREATMENT. An Exploratory Analysis of the VALUE Trial.}},
author = {P. W. de Leeuw and C. L. Söraas and G. Mancia and M. H. Mehlum and K. A. Jamerson and S. W. Schalm and S. E. Kjeldsen and M. Weber},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.18.26363450},
url = {https://www.medrxiv.org/content/10.64898/2026.09.18.26363450v1},
}
RIS
TY - UNPB
TI - PATIENT PROFILING AND OUTCOME OF ANTIHYPERTENSIVE TREATMENT. An Exploratory Analysis of the VALUE Trial.
AU - P. W. de Leeuw
AU - C. L. Söraas
AU - G. Mancia
AU - M. H. Mehlum
AU - K. A. Jamerson
AU - S. W. Schalm
AU - S. E. Kjeldsen
AU - M. Weber
PY - 2026
DA - 2026/09/18
PB - medRxiv
DO - 10.64898/2026.09.18.26363450
UR - https://www.medrxiv.org/content/10.64898/2026.09.18.26363450v1
ER -